go back

Brexucabtagene Autoleucel (Tecartus)

Virginia rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Professionalmedian $446,684 · 10th–90th $446,684$446,6840%50%100%$446,684$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
United
Setting
Professional
Modifier
Global
Typical Low
$446,683.59
Median
$446,683.59
Typical High
$446,683.59